1. Home
  2. PGEN vs ANIK Comparison

PGEN vs ANIK Comparison

Compare PGEN & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • ANIK
  • Stock Information
  • Founded
  • PGEN 1998
  • ANIK 1983
  • Country
  • PGEN United States
  • ANIK United States
  • Employees
  • PGEN N/A
  • ANIK N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • ANIK Medical/Dental Instruments
  • Sector
  • PGEN Health Care
  • ANIK Health Care
  • Exchange
  • PGEN Nasdaq
  • ANIK Nasdaq
  • Market Cap
  • PGEN 292.6M
  • ANIK 255.6M
  • IPO Year
  • PGEN N/A
  • ANIK 1993
  • Fundamental
  • Price
  • PGEN $0.76
  • ANIK $16.54
  • Analyst Decision
  • PGEN Buy
  • ANIK Buy
  • Analyst Count
  • PGEN 5
  • ANIK 2
  • Target Price
  • PGEN $7.00
  • ANIK $24.50
  • AVG Volume (30 Days)
  • PGEN 1.1M
  • ANIK 95.2K
  • Earning Date
  • PGEN 11-14-2024
  • ANIK 10-31-2024
  • Dividend Yield
  • PGEN N/A
  • ANIK N/A
  • EPS Growth
  • PGEN N/A
  • ANIK N/A
  • EPS
  • PGEN N/A
  • ANIK N/A
  • Revenue
  • PGEN $3,963,000.00
  • ANIK $164,168,000.00
  • Revenue This Year
  • PGEN N/A
  • ANIK N/A
  • Revenue Next Year
  • PGEN $402.12
  • ANIK N/A
  • P/E Ratio
  • PGEN N/A
  • ANIK N/A
  • Revenue Growth
  • PGEN N/A
  • ANIK 0.52
  • 52 Week Low
  • PGEN $0.65
  • ANIK $15.83
  • 52 Week High
  • PGEN $1.93
  • ANIK $29.12
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 43.22
  • ANIK 38.75
  • Support Level
  • PGEN $0.76
  • ANIK $15.83
  • Resistance Level
  • PGEN $0.78
  • ANIK $18.18
  • Average True Range (ATR)
  • PGEN 0.06
  • ANIK 0.62
  • MACD
  • PGEN -0.00
  • ANIK 0.05
  • Stochastic Oscillator
  • PGEN 34.93
  • ANIK 37.45

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: